Weekend Discovery｜Abilify Maintena 400 Mg Aripiprazole Extended-Release Injectable Suspension｜ Other Products

Abilify Maintena 400 Mg Aripiprazole Extended-Release Injectable SuspensionAbilify Maintena is an extended-release injectable suspension designed for the treatment of schizophrenia and bipolar I disorder. This once-monthly injection provides a consistent delivery of aripiprazole, helping to stabilize symptoms effectively.Key Features
Extended-release formulation for monthly administration
Used in the treatment of schizophrenia and bipolar I disorder
Helps maintain stable symptoms
Technical Specifications
Dosage 400 mg
Form Injectable suspension
Administration Intramuscular
Application or Use CaseIdeal for patients requiring long-term management of schizophrenia or bipolar I disorder.Typical User/Industry ProfileHealthcare professionals administering treatment for mental health disorders.About the BrandAbilify Maintena is a trusted name in the field of mental health treatment, known for its innovative approach to long-term symptom management.
Brand:Abilify MaintenaCategory:AntipsychoticsSKU:PHA13978Tags:Antipsychotic, Aripiprazole, Bipolar Disorder, ExtendedRelease, Injectable Suspension, mcenter, Pharma, Schizophrenia